Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-07-12

Clinical Trial Update: Phase II Trial of SK3530 in Erectile Dysfunction [Phase 2]

View source ↗

Summary

A Phase II trial of SK3530 for erectile dysfunction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SK3530

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Male Erectile Dysfunction | Phase 2 | Status: TERMINATED